ArticleHematological oncology2022

Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.

Fulvio Massaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.